return to news
  1. Stocks to watch, February 17: Uno Minda, ABB India, Glenmark Pharma, BHEL, Hero MotoCorp, steel stocks, RVNL, and more

Market News

Stocks to watch, February 17: Uno Minda, ABB India, Glenmark Pharma, BHEL, Hero MotoCorp, steel stocks, RVNL, and more

Upstox

9 min read | Updated on February 17, 2025, 08:29 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Rail Vikas Nigam Ltd (RVNL) on Friday, February 14, reported a 13.1% year-on-year (YoY) dip in net profit at ₹311.6 crore for the third quarter that ended December 31, 2024. In the same period in FY24, the company saw a net profit of ₹358.6 crore. Revenue fell 2.6% to ₹4,567.4 crore against ₹4,689.3 crore in the year-ago period.

At 7:50 AM, the GIFT NIFTY futures were trading at 22,975 points, or 45 points, or 0.20%

At 7:50 AM, the GIFT NIFTY futures were trading at 22,975 points, or 45 points, or 0.20%

Stocks to watch: The domestic equity market will likely open in the red on Monday, February 17.

At 7:50 AM, the GIFT NIFTY futures were trading at 22,975 points, or 45 points, or 0.20%. This suggests that the NIFTY50 index will open 21 points lower.

Asian share markets were little changed and were looking for a direction amid the Wall Street holiday on Monday.

Here is a list of stocks that may remain in focus today.
Godrej Properties: Godrej Properties acquired 12 land parcels during the April-December period of this fiscal to develop housing projects worth ₹23,450 crore and plans to buy more in the ongoing quarter to expand business amid strong consumer demand.

Godrej Properties acquires land outright and partners with landowners under new business development.

In an interview with PTI, Pirojsha Godrej, Executive Chairperson of Godrej Properties, said that "business development was powerful during the December quarter."
EaseMyTrip Q3: Online travel booking platform EaseMyTrip on Friday reported a decline in its consolidated net profit to ₹34 crore in the quarter ended December.

The company had a net profit of ₹45.68 crore in the year-ago period, according to a regulatory filing.

Its total income decreased to ₹153.81 crore against ₹165.30 crore in the October-December period under review.

GlaxoSmithKline Pharmaceuticals: The pharmaceutical company on Friday said its net profit increased more than fivefold to ₹229 crore for the third quarter ended December 31, 2024.

The drug firm reported a net profit of ₹45 crore for the October-December quarter of the last fiscal.

Revenue from operations rose to ₹949 crore for the third quarter, as compared to ₹805 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a statement.

Reliance Industries (RIL): In a setback for Mukesh Ambani-led Reliance Industries Ltd and its partner BP Plc, the Delhi High Court has overturned an international arbitration tribunal's ruling that held the duo not responsible for paying any compensation for the gas they produced and sold, which had allegedly migrated from adjoining fields.
HFCL: Domestic telecom gear maker HFCL is betting big on growth from overseas sales and uptake of defence supplies as the company looks to become a ₹ 10,000-crore revenue enterprise, a top company official said.

Mahendra Nahata, Managing Director of HFCL, during the company's recent investor call, said the firm had an order book of ₹10,000 crore as of December 31, 2024.

Utkarsh Small Finance Bank: The lender on Friday (February 14) reported a net loss of ₹168 crore for the third quarter that ended December 31, 2024.

Net interest income (NII), which is the difference between the interest income a bank earns from its lending activities and the interest it pays to depositors, dipped 0.5%, coming in at ₹480 crore against ₹482 crore in the corresponding quarter of FY24.

ABB India: The company is slated to announce its December quarter numbers today.
Bank of Maharashtra: State-owned Bank of Maharashtra (BoM) on Sunday said it has received approval from the Reserve Bank of India to set up an International Financial Services Centre (IFSC) Banking Unit at GIFT City.

The branch will function as Bank of Maharashtra's first international branch, carrying out offshore banking operations from India.

Speaking on the development, BoM MD & CEO Nidhu Saxena said, "This is a significant opportunity for our bank as we continue to expand our operations across geographies. The opening of IBU in GIFT City will be yet another milestone in the bank's growth story."

RVNL: Rail Vikas Nigam Ltd (RVNL) on Friday, February 14, reported a 13.1% year-on-year (YoY) dip in net profit at ₹311.6 crore for the third quarter that ended December 31, 2024. In the same period in FY24, the company saw a net profit of ₹358.6 crore.

Revenue fell 2.6% to ₹4,567.4 crore against ₹4,689.3 crore in the year-ago period.

Further, EBITDA (earnings before interest, tax, depreciation, and amortisation) was down 3.9% YoY to ₹239.4 crore in Q3FY25 over ₹249 crore. The EBITDA margin was largely flat at 5.2% compared to 5.3% in the corresponding period in the previous fiscal.

Samvardhana Motherson: The auto component maker on Friday reported a consolidated net profit of ₹879 crore for the third quarter ended December 31, 2024.

The company had reported a net profit of ₹542 crore for the October-December quarter of the last fiscal.

Total revenue from operations rose to ₹27,666 crore for the third quarter of this fiscal year, as compared to ₹25,644 crore in the year-ago period, Samvardhana Motherson International said in a regulatory filing.

Uno Minda: Auto components maker Uno Minda on Friday said its board has approved the acquisition of the remaining 49.9% stake in a joint venture firm from partner FRIWO Geratebau GmbH for ₹195 crore.

The company announced in a statement that it will increase its share in UnoMinda EV Systems from 50.10% to 100%.

Uno Minda, through its subsidiaries, will also acquire the intellectual property rights and R&D assets relating to the e-drive business technologies from FRIWO's locations in Germany and Vietnam, it added.

Fortis Healthcare: Fortis Healthcare (FHL) on Friday said it will acquire Shrimann Superspecialty Hospital in Jalandhar, Punjab, for ₹462 crore through its wholly owned subsidiary—Fortis Hospital.

The healthcare company has signed definitive agreements for the acquisition of Shrimann Hospital from Shriman Enterprises (a partnership firm) by way of a slump sale, FHL said in a statement.

The acquisition would be undertaken by FHL's wholly owned subsidiary Fortis Hospotel Limited (FHTL) and is subject to FHL shareholder approval.

Northern Arc Capital: NBFC Northern Arc Capital on Friday reported an almost flat consolidated net profit at ₹76 crore in the third quarter ended December 2024.

The lender had earned a net profit of ₹75 crore in the same quarter a year ago.

The total income on a consolidated basis increased to ₹581 crore during the quarter under review against ₹497 crore in the same quarter last year, Northern Arc Capital Ltd said in a regulatory filing.

Glenmark Pharma: Glenmark Pharmaceuticals on Friday said its consolidated profit after tax stood at ₹348 crore for the third quarter ended December 31, 2024, aided by strong performance across regions.

The drug firm reported a loss of ₹351 crore in the October-December quarter of the last fiscal.

Consolidated revenue stood at ₹3,388 crore in the third quarter as against ₹2,507 crore in the year-ago period, the Mumbai-based company said in a statement.

BHEL: State-run engineering firm Bharat Heavy Electricals Ltd (BHEL) on Friday said it has secured an order worth 6,700 crore from Singareni Collieries Company (SCCL) to set up an 800 MW thermal power unit in Telangana.

Under this contract, BHEL's scope of work includes design, engineering, manufacturing, supply, erection, and commissioning, along with civil works, a company statement said.

BHEL has secured an order from SCCL for setting up the 800 MW Adilabad supercritical thermal power project in Mancherial district, Telangana, on an EPC (Engineering, Procurement & Construction) basis.

Mahindra Lifespace: Real estate company Mahindra Lifespace Developers plans to raise up to ₹1,500 crore through the issue of shares to eligible shareholders for reducing its debt as well as funding further growth.

The board of Mahindra Lifespaces Developrs has approved the fundraising of up to ₹1,500 crore through a rights issue to the eligible shareholders of the company.

The proceeds will be utilised to pare down the company's existing debt and support its future growth plans, according to a regulatory filing on February 13.

Mahindra Lifespace is the real estate and infrastructure development business of the Mahindra Group.

Reliance Infrastructure: Reliance Infrastructure Ltd has reported a widening of consolidated net loss to ₹3,298.35 crore in the December quarter.

It had clocked a net loss of ₹421.17 crore in the year-ago period, the company said in an exchange filing.

The company's total income, however, rose to ₹5,129.07 crore from ₹4,717.09 crore in the same period a year ago.

Its expenses declined to ₹4,963.23 crore from ₹5,068.71 crore in the third quarter of the previous fiscal.

SAIL: SAIL is bullish on the demand for rails in the country and has decided to set up a new rail mill at an investment of USD 800 million, the company's Chairman Amarendu Prakash said on Saturday.

The company has decided to go ahead with the investment plan despite not having any order indication from its largest buyer, Indian Railways, Prakash said at a panel discussion at the Global Business Summit (GBS) in the national capital.

The chairman said such a kind of confidence is a result of the growth-oriented policies of the government.

Steel stocks: Shares of steel companies are expected to be in focus as Jindal Steel and Power Ltd (JSPL) chairman Naveen Jindal said on Saturday that the domestic steel industry needs to be on guard as countries exporting to the US may divert shipments to India after the imposition of tariffs, an industry official said on Saturday.
Hero MotoCorp: The country's largest two-wheeler maker, Hero MotoCorp, expects double-digit revenue growth next fiscal year, riding on the back of continued investments in new products and segments, according to Chief Financial Officer Vivek Anand.

The company, which reported a revenue of ₹10,260 crore for the December quarter, also anticipates a double-digit revenue growth in the current fiscal.

"This year, the guidance we have given is for double-digit revenue growth. Looking at our first nine months performance and looking at how this quarter (fourth) has started, we believe that there will be a repeat next year, a double-digit revenue growth," Anand said in an analyst call.

Aurobindo Pharma: Aurobindo Pharma will commence supplies to Europe from its China facility from April onwards, according to Chief Financial Officer Santhanam Subramanian.

The Hyderabad-based drug maker commenced operations at the facility in the last week of November 2024 and is now ramping up production.

"The China plant will start billing sometime in April, mainly to the European markets," Subramanian told analysts in a call.

M&M: Mahindra & Mahindra on Friday said it has secured 30,179 bookings for its two new electric models -- XEV 9e and BE 6.

The Mumbai-based auto major claimed the booking number translates to a value of ₹8,472 crore (at ex-showroom price).

The company commenced bookings for the complete lineup of XEV 9e and BE 6 on Friday.

Upstox

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Next Story